See the source article by following the link below:
Moving towards the end of chemotherapy: in a Phase 3 trial, replacing the harsh chemo drug, bleomycin, with the targeted therapy, Adcetris, improved outcomes and reduced lung toxicity.
Moving towards the end of chemotherapy: in a Phase 3 trial, replacing the harsh chemo drug, bleomycin, with the targeted therapy, Adcetris, improved outcomes and reduced lung toxicity.
No comments:
Post a Comment
I will publish your valuable comment after reviewing it. Thanks for your patience!